MarketPulse — Real-Time Financial News & Market Analysis

ALS therapeutics market to more than double by 2035, reaching $1.96 billion. Growth driven by genetic therapies, improved diagnostics, and disease awareness.

Amazon's federal tax bill dropped to $1.2B from $9B due to new depreciation rules and R&D credits, despite higher profits, sparking criticism over corporate tax relief.

Palantir gets DISA authorization for cloud services across U.S. defense operations, streamlining deployment with highest security clearances. Strong commercial growth continues.

Citymesh launches cloud-native 5G core service via AWS and Nokia, shifting telecom from costly hardware to subscription-based SaaS model for easier scaling.

Dividend Aristocrats—companies with 25+ years of consecutive dividend increases—offer reliable income and stability for retirement investors, though individual evaluation of valuations and sustainability remains essential.

Technip Energies appoints Jesse Stanley as President of Technologies & Products, effective March 2026, as part of executive restructuring to boost innovation and competitive positioning.

Technip Energies appoints Jesse Stanley as President of Technologies & Products, effective March 2026. She joins the Executive Committee, bringing extensive operations and innovation experience from Wood and Shell.

Eupraxia Pharmaceuticals raises $55M via public offering to advance EP-104GI for eosinophilic esophagitis through Phase 2/3 development and expand GI pipeline.

Advanced malware detection market projected to grow from $10.94B in 2025 to $31.17B by 2033, driven by escalating cyber threats and AI-powered security adoption.

Coca-Cola and Lowe's are reliable dividend stocks with 64 and 25+ years of consecutive increases respectively, offering steady income for long-term portfolios despite modest growth potential.

DOJ investigates Warner Bros. sale for theatrical impact. Netflix commits to 45-day exclusive theatrical window for films amid competitive bidding process.

Defensive sectors like utilities and healthcare outperform as investors rotate away from expensive tech stocks, signaling shifting risk appetite in markets.

SpaceX plans a potential 2026 IPO valued at $1.25-$1.5 trillion, potentially raising $50 billion. The aerospace company combines commercial rocket launches, Starlink satellite services, and AI operations.

AI investment focus shifts from chip makers to infrastructure: networking, thermal management, power systems, and cloud providers gaining investor attention as valuations for traditional semiconductors peak.

Vanguard's Mega Cap Growth ETF surged 78% since 2023, driven by 45.3% concentration in tech giants Nvidia, Apple, Microsoft, and Alphabet, though advisors warn of elevated risk.

IonQ achieves record 99.99% quantum gate fidelity through trapped-ion technology and Oxford Ionics acquisition, advancing toward commercial viability despite ongoing technical challenges.

Kyndryl faces securities class action after disclosing internal control weaknesses, CFO/General Counsel departures, and 55% stock decline. Lead plaintiff deadline is April 13, 2026.

Securities lawsuit filed against Ardent Health for alleged accounting misrepresentations. Lead plaintiff deadline set for March 9, 2026.

B2Gold shares fell 8.92% despite record 2025 revenue of $3.06 billion, as 2026 guidance projects lower production and significantly higher costs.

Ultragenyx faces securities lawsuit after failing to disclose setrusumab trial failure, causing 42% stock drop. Investors claim company withheld material information before December announcement.